Article
Mutational spectrum and risk stratification of intermediate-risk acute myeloid leukemia patients based on next-generation sequencing.
Oncotarget - 31 May 2016
Wang Bianhong, Liu Yangyang, Hou Guangyuan, Wang Lili, Lv Na, Xu Yuanyuan, Xu Yihan, Wang Xiuli, Xuan Zhaoling, Jing Yu, Li Honghua, Jin Xiangshu, Deng Ailing, Wang Li, Gao Xiaoning, Dou Liping, Liang Junbin, Chen Chongjian, Li Yonghui, Yu Li
Abstract excerpt
Intermediate-risk acute myeloid leukemia (IR-AML), which accounts for a substantial number of AML cases, is highly heterogeneous. Although several mutations have been identified, the heterogeneity of AML is uncertain because novel mutations have yet to be discovered. Here we applied next generation sequencing (NGS) platform to screen mutational hotspots in 410 genes relevant to hematological malignancy. IR-AML...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
